Basal μ-opioid receptor availability in the amygdala predicts the inhibition of pain-related brain activity during heterotopic noxious counter-stimulation

Neuroscience Research

Volumn 81-82, Issue , 2014, Pages 78-84

  Piché, Mathieu ^a,b   Watanabe, Nobuhiro ^b   Sakata, Muneyuki ^b   Oda, Keiichi ^b   Toyohara, Jun ^b   Ishii, Kenji ^b   Ishiwata, Kiichi ^b   Hotta, Harumi ^b  

^a UNIVERSITÉ DU QUÉBEC À TROIS RIVIÈRES   (Canada)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

Author keywords

Amygdala; Carfentanil; Conditioned pain modulation; Diffuse noxious inhibitory controls; Pain; Opioid receptors

Indexed keywords

CARBON 11; CARFENTANIL; CARFENTANIL C11; MU OPIATE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AMPLITUDE MODULATION; AMYGDALOID NUCLEUS; ANTERIOR CINGULATE; ANTINOCICEPTION; ARTICLE; COLD; ELECTROENCEPHALOGRAM; EVOKED SOMATOSENSORY RESPONSE; FEMALE; FLEXOR REFLEX; HETEROTOPIC NOXIOUS COUNTER STIMULATION; HUMAN; HUMAN EXPERIMENT; MALE; NOCICEPTIVE STIMULATION; NORMAL HUMAN; PAIN; PAIN THRESHOLD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SCALP; SURAL NERVE; TRANSCUTANEOUS NERVE STIMULATION; VASOCONSTRICTION; ANALGESIA; BRAIN; ELECTROSTIMULATION; METABOLISM; NERVE CELL INHIBITION; PAIN MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; REFLEX;

AMYGDALA; ANALGESIA; BRAIN; COLD TEMPERATURE; ELECTRIC STIMULATION; EVOKED POTENTIALS, SOMATOSENSORY; FEMALE; HUMANS; MALE; NEURAL INHIBITION; PAIN; PAIN MEASUREMENT; RECEPTORS, OPIOID, MU; REFLEX;

EID: 84902298141     PISSN: 01680102     EISSN: 18728111     Source Type: Journal    
DOI: 10.1016/j.neures.2014.02.006     Document Type: Article

References (41)

1. Arendt-Nielsen L., Gotliebsen K. Segmental inhibition of laser-evoked brain potentials by ipsi- and contralaterally applied cold pressor pain. Eur. J. Appl. Physiol. Occup. Physiol. 1992, 64:56-61.
2. Baraniuk J.N., Whalen G., Cunningham J., Clauw D.J. Cerebrospinal fluid levels of opioid peptides in fibromyalgia and chronic low back pain. BMC Musculoskelet. Disord. 2004, 5:48.
3. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 1984, 7:309-338.
4. Bernard J.F., Besson J.M. The spino(trigemino)pontoamygdaloid pathway: electrophysiological evidence for an involvement in pain processes. J. Neurophysiol. 1990, 63:473-490.
5. Bouhassira D., Le Bars D., Bolgert F., Laplane D., Willer J.C. Diffuse noxious inhibitory controls in humans: a neurophysiological investigation of a patient with a form of Brown-Sequard syndrome. Ann. Neurol. 1993, 34:536-543.
6. Bouhassira D., Moisset X., Jouet P., Duboc H., Coffin B., Sabate J.M. Changes in the modulation of spinal pain processing are related to severity in irritable bowel syndrome. Neurogastroenterol. Motil. 2013, 25:623-e468.
7. Burstein R., Potrebic S. Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat. J. Comp. Neurol. 1993, 335:469-485.
8. Chen A.C., Treede R.D., Bromm B. Tonic pain inhibits phasic pain: evoked cerebral potential correlates in man. Psychiatry Res. 1985, 14:343-351.
9. Cliffer K.D., Burstein R., Giesler G.J. Distributions of spinothalamic, spinohypothalamic, and spinotelencephalic fibers revealed by anterograde transport of PHA-L in rats. J. Neurosci. 1991, 11:852-868.
10. DeBroucker T., Cesaro P., Willer J.C., Le Bars D. Diffuse noxious inhibitory controls in man. Involvement of the spinoreticular tract. Brain 1990, 113:1223-1234.
11. Dowman R. Pain-evoked anterior cingulate activity generating the negative difference potential may reflect response selection processes. Psychophysiology 2002, 39:369-379.
12. Dowman R., Darcey T., Barkan H., Thadani V., Roberts D. Human intracranially-recorded cortical responses evoked by painful electrical stimulation of the sural nerve. Neuroimage 2007, 34:743-763.
13. Harris R.E., Clauw D.J., Scott D.J., McLean S.A., Gracely R.H., Zubieta J.K. Decreased central mu-opioid receptor availability in fibromyalgia. J. Neurosci. 2007, 27:10000-10006.
14. Innis R.B., Cunningham V.J., Delforge J., Fujita M., Gjedde A., Gunn R.N., Holden J., Houle S., Huang S.C., Ichise M., Iida H., Ito H., Kimura Y., Koeppe R.A., Knudsen G.M., Knuuti J., Lammertsma A.A., Laruelle M., Logan J., Maguire R.P., Mintun M.A., Morris E.D., Parsey R., Price J.C., Slifstein M., Sossi V., Suhara T., Votaw J.R., Wong D.F., Carson R.E. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
15. 11C]carfentanil using an extraction disk instead of HPLC. Nucl. Med. Biol. 2001, 28:733-734.
16. Julien N., Goffaux P., Arsenault P., Marchand S. Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 2005, 114:295-302.
17. 2 laser stimulation. J. Neurol. Sci. 1994, 125:198-205.
18. Kawasaki K., Ishii K., Saito Y., Oda K., Kimura Y., Ishiwata K. Influence of mild hyperglycemia on cerebral FDG distribution patterns calculated by statistical parametric mapping. Ann. Nucl. Med. 2008, 22:191-200.
19. Kosek E., Hansson P. Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects. Pain 1997, 70:41-51.
20. Ladouceur A., Tessier J., Provencher B., Rainville P., Piché M. Top-down attentional modulation of analgesia induced by heterotopic noxious counterstimulation. Pain 2012, 153:1755-1762.
21. Lautenbacher S., Rollman G.B. Possible deficiencies of pain modulation in fibromyalgia. Clin. J. Pain 1997, 13:189-196.
22. LeBars D., Dickenson A.H., Besson J.M. Diffuse noxious inhibitory controls (DNIC). I. Effects on dorsal horn convergent neurones in the rat. Pain 1979, 6:283-304.
23. Lenz F.A., Rios M., Zirh A., Chau D., Krauss G., Lesser R.P. Painful stimuli evoke potentials recorded over the human anterior cingulate gyrus. J. Neurophysiol. 1998, 79:2231-2234.
24. Logan J., Fowler J.S., Volkow N.D., Wang G.J., Ding Y.S., Alexoff D.L. Distribution volume ratios without blood sampling from graphical analysis of PET data. J. Cereb. Blood Flow Metab. 1996, 16:834-840.
25. Manning B.H., Mayer D.J. The central nucleus of the amygdala contributes to the production of morphine antinociception in the rat tail-flick test. J. Neurosci. 1995, 15:8199-8213.
26. Moont R., Crispel Y., Lev R., Pud D., Yarnitsky D. Temporal changes in cortical activation during conditioned pain modulation (CPM), a LORETA study. Pain 2011, 152:1469-1477.
27. Piché M., Arsenault M., Rainville P. Cerebral and cerebrospinal processes underlying counterirritation analgesia. J. Neurosci. 2009, 29:14236-14246.
28. Piché M., Bouin M., Arsenault M., Poitras P., Rainville P. Decreased pain inhibition in irritable bowel syndrome depends on altered descending modulation and higher-order brain processes. Neuroscience 2011, 195:166-175.
29. Ray R., Ruparel K., Newberg A., Wileyto E.P., Loughead J.W., Divgi C., Blendy J.A., Logan J., Zubieta J.K., Lerman C. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:9268-9273.
30. Rizvi T.A., Ennis M., Behbehani M.M., Shipley M.T. Connections between the central nucleus of the amygdala and the midbrain periaqueductal gray: topography and reciprocity. J. Comp. Neurol. 1991, 303:121-131.
31. Sprenger C., Bingel U., Buchel C. Treating pain with pain: supraspinal mechanisms of endogenous analgesia elicited by heterotopic noxious conditioning stimulation. Pain 2011, 152:428-439.
32. 2 laser. J. Clin. Neurophysiol. 1993, 10:513-519.
33. 3H]carfentanil in human and rat brain. Eur. J. Pharmacol. 1989, 167:221-228.
34. 2 laser stimulation of the hand. Electroencephalogr. Clin. Neurophysiol. 1996, 100:343-353.
35. Watanabe S., Kakigi R., Hoshiyama M., Kitamura Y., Koyama S., Shimojo M. Effects of noxious cooling of the skin on pain perception in man. J. Neurol. Sci. 1996, 135:68-73.
36. Willer J.C. Comparative study of perceived pain and nociceptive flexion reflex in man. Pain 1977, 3:69-80.
37. Willer J.C., DeBroucker T., LeBars D. Encoding of nociceptive thermal stimuli by diffuse noxious inhibitory controls in humans. J. Neurophysiol. 1989, 62:1028-1038.
38. Willer J.C., Roby A., LeBars D. Psychophysical and electrophysiological approaches to the pain-relieving effects of heterotopic nociceptive stimuli. Brain 1984, 107:1095-1112.
39. Worsley K.J., Evans A.C., Marrett S., Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J. Cereb. Blood Flow Metab. 1992, 12:900-918.
40. Yarnitsky D., Arendt-Nielsen L., Bouhassira D., Edwards R.R., Fillingim R.B., Granot M., Hansson P., Lautenbacher S., Marchand S., Wilder-Smith O. Recommendations on terminology and practice of psychophysical DNIC testing. Eur. J. Pain 2010, 14:339.
41. Zubieta J.K., Smith Y.R., Bueller J.A., Xu Y., Kilbourn M.R., Jewett D.M., Meyer C.R., Koeppe R.A., Stohler C.S. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Science 2001, 293:311-315.